Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
magazineReturn from our 2023 share picks is more than four times that of the UK market
Our 2023 picks have smashed it - achieving an average return excluding dividends of 20.6%, more than four times the return of the FTSE All-Share and better even than the MSCI World which is up 17.9% this year.
This is all the more satisfying as the MSCI World index has been powered by the US ‘Magnificent Seven’ tech stocks, whereas the Shares portfolio benefited from the inclusion of just one of this group: Apple (AAPL:NASDAQ).
Important information:
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.
Issue contents
Case study
Feature
- Return from our 2023 share picks is more than four times that of the UK market
- The best and worst emerging markets in 2023
- Can electricals leader Currys deliver some turnaround spark?
- Discover the stocks the professionals changed their minds on in 2023
- Emerging markets: China property fixes and dollar weakness
Great Ideas
- 10 stocks for 2024: our best ideas for the year ahead
- Stock pick for 2024: Adobe is one of the best ways to play AI
- Stock pick for 2024: Buy Smith & Nephew for continued recovery and re-rating potential
- Stock pick for 2024: Buy Puretech Health for lower risk access to an exciting drug portfolio
- Stock pick for 2024: MongoDB is one of the hottest software plays on AI
- Stock pick for 2024: B&M's growth ambitions and value focus make it a compelling story
- Stock pick for 2024: Hunting is attractively priced and evidence of transformation is a clear catalyst
- Stock pick for 2024: The market has not spotted RELX for the AI winner it is
- Stock pick for 2024: Just Group is so cheap and has big growth drivers behind it
- Stock pick for 2024: Hollywood Bowl is a strikingly resilient operator trading at the wrong price
- Stock pick for 2024: Take advantage of this 'generational opportunity' to buy Conduit
Investment Trusts
News
- How TSMC could set the New Year tone for tech
- Markets higher despite mixed rates messaging and what to expect from retailers
- Discover the most unloved and most-shorted UK stocks
- Costco climbs to all-time high as members clamour for cheap essentials
- A big acquisition and a slowdown in its largest market have unnerved investors in Rentokil
- UK housebuilders Taylor Wimpey and Persimmon have moved-up strongly
